Galapagos Competitors

Pink Sheets . USA . 
Stock . Galapagos NV
GLPGF Stock  USD 26.26  0.00  0.00%   
Galapagos NV competes with NewAmsterdam Pharma, Portage Biotech, DBV Technologies, NewAmsterdam Pharma, and Centessa Pharmaceuticals; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Galapagos competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Galapagos to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Galapagos Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Galapagos competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
25.4426.2627.08
Details
Intrinsic
Valuation
LowRealHigh
25.0125.8326.65
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Galapagos. Your research has to be compared to or analyzed against Galapagos' peers to derive any actionable benefits. When done correctly, Galapagos' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Galapagos NV.

Galapagos Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Galapagos and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Galapagos and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Galapagos NV does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
NAMSW
+ 0.97
NAMS
STRO
+ 0.73
EFTRW
STRO
+ 0.67
DBVT
HLVX
+ 0.64
NAMSW
HLVX
+ 0.61
NAMS
CNTA
+ 0.56
NAMS
  
High negative correlations   
CNTA
- 0.7
DBVT
STRO
- 0.59
CNTA
CNTA
- 0.58
EFTRW
DBVT
- 0.57
NAMS
OPT
- 0.55
EFTRW
NAMS
- 0.54
EFTRW

Risk-Adjusted Indicators

There is a big difference between Galapagos Pink Sheet performing well and Galapagos Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Galapagos' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Galapagos Competitive Analysis

The better you understand Galapagos competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Galapagos' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Galapagos' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
GLPGF EFTRW NAMS PRTG DBVT NAMSW CNTA STRO OPT HLVX
 0.00 
 26.26 
Galapagos
 0.00 
 0 
EFFECTOR
 4.57 
 19.85 
NewAmsterdam
 0.71 
 4.18 
Portage
 27.04 
 3.90 
DBV
 6.50 
 9.06 
NewAmsterdam
 1.76 
 17.91 
Centessa
 1.49 
 2.65 
Sutro
 10.81 
 3.69 
Opthea
 0.52 
 1.93 
Hillevax
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Not too volatile
Dangerous
Very risky
Moderately volatile
Slightly risky
Relatively risky
Moderately volatile
Not too volatile
Market Performance
(90 Days Performance)
OK
Very Weak
OK
Modest
Very Weak
OK
OK
Very Weak
OK
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Dangerous
About Average
High
Low
High
Low
About Average
High
High
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Under Valued
Under Valued
Under Valued
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Hold
Buy
Strong Sell
Strong Buy
Strong Buy
Strong Buy
Hold
Trade Advice
(90 Days Macroaxis Advice)
Hold
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Sell
Strong Sell
Strong Sell
Strong Hold
Current Ratio
8.23
N/A
N/A
11.73
8.54
N/A
15.48
7.44
4.97
34.77
Net Asset
5.19 B
20.54 M
347.1 M
7.78 M
182.99 M
347.1 M
360.25 M
470.74 M
188.79 M
344.43 M
Profit Margin
0.0096
N/A
N/A
N/A
N/A
N/A
N/A
-0.77
N/A
N/A
EBITDA
(76.71 M)
(33.73 M)
(176.86 M)
(18.2 M)
(79.53 M)
(176.86 M)
(166.07 M)
(67.92 M)
(200.02 M)
(132.47 M)
Operating Margin
-0.17
N/A
-0.86
N/A
-28.29
-0.86
-23.59
-7.97
N/A
N/A
Current Valuation
(2.11 B)
N/A
1.5 B
2.96 M
24.67 M
N/A
1.89 B
(141.58 M)
483.28 M
(68.71 M)
Price To Book
0.92
N/A
5.07
3.36
1.39
N/A
4.65
1.99
4.31
0.52
Retained Earnings
(162 M)
(179.38 M)
(316.97 M)
(239.32 M)
(238.86 M)
(316.97 M)
(752.95 M)
(559.41 M)
(579.7 M)
(388.56 M)
Current Asset
963 M
N/A
N/A
N/A
334.89 M
N/A
N/A
N/A
N/A
N/A
Beta
0.0688
0.62
-0.001
99.48
0.86
-0.001
1.48
1.17
1.54
0.77
Number Of Employees
1.36 K
14
62
7
108
62
76
302
33
90
Shares Outstanding
65.84 M
N/A
92.39 M
1.12 M
19.24 M
N/A
131.84 M
82.46 M
153.89 M
49.81 M
Cash Flow From Operations
(503.83 M)
(29.55 M)
(141.22 M)
(14.3 M)
(79.65 M)
(141.22 M)
(160.34 M)
(111.62 M)
(161.02 M)
(86.78 M)
Total Debt
24.05 M
19.45 M
60 K
47 K
6.55 M
60 K
84.59 M
33.63 M
141.65 M
51.19 M
Return On Equity
0.0021
-9.47
-0.47
-1.91
-1.03
-0.47
-0.43
-1.11
-33.83
-0.62
Z Score
70.8
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.0119
-0.83
-0.29
-0.19
-0.46
-0.29
-0.2
-0.18
-0.83
-0.29
Book Value Per Share
40.87
0.21
4.11
4.07
0.56
4.11
4.29
1.82
-0.069
3.82
Number Of Shares Shorted
N/A
18.44 K
1.01 M
10.04 K
1.26 M
3.47 K
2.44 M
1.79 M
65.63 K
1.21 M
Current Liabilities
130 M
N/A
N/A
N/A
16.02 M
N/A
N/A
N/A
N/A
N/A
Total Asset
5.19 B
20.54 M
347.1 M
7.78 M
182.99 M
347.1 M
360.25 M
470.74 M
188.79 M
344.43 M
Debt To Equity
0.009
N/A
N/A
N/A
0.016
N/A
0.16
0.27
N/A
0.09
Target Price
66.05
N/A
37.0
140.0
27.41
N/A
28.57
12.0
12.17
3.0
Short Ratio
N/A
N/A
2.92
0.17
0.74
N/A
5.59
3.26
1.88
8.85
Shares Owned By Institutions
32.13
N/A
84.04
17.8
16.7
N/A
92.52
77.1
3.57
75.29
Market Capitalization
2.85 B
N/A
2.29 B
4.72 M
75.04 M
N/A
2.32 B
218.52 M
543.93 M
95.63 M
Price To Earning
454.11
N/A
N/A
N/A
-8.25
N/A
N/A
53.08
N/A
N/A
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.12
N/A
N/A
Price To Sales
4.51
N/A
57.2
N/A
6.0
N/A
338.61
1.36
2077.17
N/A
Net Income
(103.23 M)
(35.81 M)
(160.27 M)
(75.34 M)
(72.73 M)
(160.27 M)
(151.09 M)
(106.79 M)
(220.24 M)
(123.57 M)
Earnings Per Share
0.1
-0.9
-2.21
-68.17
-5.3
N/A
-1.52
-1.55
-2.76
-3.09
Shares Owned By Insiders
26.24
N/A
0.25
29.8
N/A
N/A
1.31
0.96
N/A
17.11
Revenue
484.85 M
N/A
12.76 M
N/A
4.16 M
12.76 M
6.85 M
153.73 M
124.67 K
N/A
Working Capital
833 M
(5.96 M)
296.89 M
4.82 M
121.58 M
296.89 M
275.71 M
327.8 M
124.14 M
281.41 M
Cash And Equivalents
4.43 B
N/A
N/A
21.18 M
247.97 M
N/A
484.16 M
225.64 M
44.63 M
292.06 M
Cash Per Share
67.38
N/A
N/A
1.25
1.32
N/A
5.13
4.33
1.01
9.81
Gross Profit
(8.49 M)
N/A
N/A
N/A
4.84 M
N/A
N/A
(42.52 M)
218.45 K
N/A
Day Typical Price
26.26
0.001
20.02
4.27
3.68
8.91
17.84
2.68
3.56
1.93
Accumulation Distribution
N/A
N/A
32035.66
1465.11
21145.83
54.2
22464.87
28922.56
2369.59
1648.36
Market Facilitation Index
N/A
N/A
0.0
0.0
0.0
4.0E-4
0.0
N/A
0.0
0.0
Daily Balance Of Power
0.0
0.0
(0.56)
(0.07)
1.276923
(1.43)
0.4627
(0.36)
0.9474
0.2
Period Momentum Indicator
N/A
N/A
(0.95)
(0.03)
0.83
(0.63)
0.31
(0.04)
0.36
0.01
Rate Of Daily Change
1.0
1.0
0.95
0.99
1.27
0.93
1.02
0.99
1.11
1.01
Day Median Price
26.26
0.001
20.11
4.31
3.58
8.84
17.81
2.7
3.5
1.92
Price Action Indicator
N/A
N/A
(0.73)
(0.15)
0.74
(0.1)
0.26
(0.07)
0.37
0.01
Relative Strength Index
N/A
38.48
82.12
32.76
36.36
84.46
65.13
74.51
38.9
56.77
Coefficient Of Variation
760.93
4038.44
994.72
4656.65
23893.82
1773.27
767.91
(700.36)
1042.81
5614.76
Mean Deviation
0.2038
20.69
2.35
8.45
4.14
3.86
2.81
3.41
3.21
1.61
Jensen Alpha
0.0907
1.06
0.0742
0.4834
(0.07)
0.211
0.3552
(1.08)
0.255
(0.1)
Total Risk Alpha
(0.04)
(5.00)
(0.25)
(2.56)
(1.08)
(0.77)
(0.15)
(1.60)
(0.33)
(0.32)
Sortino Ratio
N/A
0.0228
0.0614
0.0221
(0.02)
0.0296
0.1049
N/A
0.0695
(0.05)
Downside Variance
N/A
1033.87
13.5
117.23
24.38
71.3
12.2
N/A
18.28
4.76
Standard Deviation
0.7997
35.13
3.61
17.53
6.54
6.87
3.87
5.12
4.53
2.09
Kurtosis
65.34
4.8
7.11
32.54
6.94
6.8
1.15
3.1
1.26
0.0655
Potential Upside
N/A
67.39
5.33
10.92
6.38
8.53
8.37
7.81
9.15
3.8
Treynor Ratio
2.74
(0.54)
0.1616
(0.40)
0.0266
0.2891
0.4543
(0.28)
0.3193
0.0279
Maximum Drawdown
6.49
201.01
29.23
134.05
36.79
50.47
21.09
30.73
24.2
9.82
Variance
0.6395
1233.97
13.05
307.29
42.83
47.25
14.98
26.21
20.56
4.39
Market Risk Adjusted Performance
2.75
(0.53)
0.1716
(0.39)
0.0366
0.2991
0.4643
(0.27)
0.3293
0.0379
Risk Adjusted Performance
0.1009
0.0287
0.0847
0.026
0.012
0.052
0.1076
(0.10)
0.0816
0.02
Skewness
8.07
1.15
(0.47)
4.82
2.02
(0.31)
0.5899
(0.55)
0.3015
0.2999
Semi Deviation
N/A
25.07
3.39
10.48
4.61
6.16
3.08
N/A
3.83
1.85
Information Ratio
(0.04)
0.0208
0.0624
0.0136
(0.02)
0.0364
0.0947
(0.17)
0.0655
(0.05)
Value At Risk
N/A
(48.07)
(4.57)
(14.59)
(8.65)
(8.05)
(5.69)
(8.71)
(7.49)
(3.33)
Expected Short fall
N/A
(34.99)
(2.63)
(8.82)
(5.28)
(5.10)
(3.14)
N/A
(3.73)
(1.93)
Downside Deviation
N/A
32.15
3.67
10.83
4.94
8.44
3.49
N/A
4.28
2.18
Semi Variance
N/A
628.43
11.49
109.74
21.23
38.0
9.47
N/A
14.71
3.43

Galapagos Competition Performance Charts

Five steps to successful analysis of Galapagos Competition

Galapagos' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Galapagos NV in relation to its competition. Galapagos' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Galapagos in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Galapagos' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Galapagos NV, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Galapagos position

In addition to having Galapagos in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Outsourcing Thematic Idea Now

Outsourcing
Outsourcing Theme
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Galapagos Pink Sheet

Galapagos financial ratios help investors to determine whether Galapagos Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Galapagos with respect to the benefits of owning Galapagos security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY